Mark Wilterding | VP, IR and Treasurer |
Mike Mussallem | Chairman and CEO |
Scott Ullem | CFO |
Larry Wood | Global Leader, TAVR |
Bernard Zovighian | Global Leader, TMTT |
Robbie Marcus | JPMorgan |
Larry Biegelsen | Wells Fargo |
Vijay Kumar | Evercore ISI |
Joanne Wuensch | Citi |
Cecilia Furlong | Morgan Stanley |
Travis Steed | Bank of America |
Suraj Kalia | Oppenheimer |
Ed Ridley | Redburn |
Bill Plovanic | Canaccord |
Adam Maeder | Piper Sandler |
Josh Jennings | Cowen |
Greetings, and welcome to the Edwards Lifesciences' Second Quarter 2022 Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note that this conference is being recorded. I will now turn the conference over to our host, Mark Wilterding, Vice President, Investor Relations and Treasurer.